ADCE-D01

· Adcendo ApS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADCE-D01, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma [Phase 1, Phase 2]